Updates in Gynecologic Cancers: Immunotherapy in Cervical and Endometrial Cancers
This site is intended for healthcare professionals only.
The content on this page is for updated scientific information exchange. MSD does not encourage any off-label prescription. Please prescribe the drug or medicine based on your country’s prescribing information.
For more information about Pembrolizumab, please visit our M-Connect portal